Reuters logo
Pfizer, Roche and Aspen face South Africa probe over cancer drug prices
June 13, 2017 / 12:11 PM / 5 months ago

Pfizer, Roche and Aspen face South Africa probe over cancer drug prices

PRETORIA (Reuters) - South Africa’s competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency’s head Tembinkosi Bonakele said on Tuesday.

FILE PHOTO: The Pfizer logo is seen at their world headquarters in New York April 28, 2014. REUTERS/Andrew Kelly/File Photo

The Competition Commission said it will investigate Aspen Pharmacare, Africa’s biggest generic drug maker, U.S. company Pfizer and Swiss-based Roche Holding.

Reporting by Nqobile Dludla. Editing by Jane Merriman

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below